Nuclear Medicine Therapy Market Size, Trends, Share, Growth, and Opportunity Forecast, 2025 – 2032 Global Industry Analysis By Type (Radioisotope Therapy, Peptide Receptor Radionuclide Therapy (PRRT), Radioimmunotherapy, and Brachytherapy), By Application (Cancer Treatment, Cardiovascular Disorders, Neurological Disorders, and Thyroid Disorders), By End-User (Hospitals, Diagnostic Centers, and Research Laboratories), and By Geography (North America, Europe, Asia Pacific, South America, and Middle East & Africa)

Chapter 1.    Executive Summary

1.1.  Global Nuclear Medicine Therapy Market Size and Forecast, 2020 - 2032 (USD Million)

1.2.  Global Nuclear Medicine Therapy Market Snapshot, by Segmentation

1.3.  Global Nuclear Medicine Therapy Market Snapshot, by Region

1.4.  Global Nuclear Medicine Therapy Market Snapshot, by Manufacturers

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Scope, Definition, and Assumptions

2.3.  Data Sources

2.3.1.Secondary Sources

2.3.1.1.         Preliminary Data Mining

2.3.2.Primary Sources

2.3.2.1.         Statistical Model

2.3.2.2.         Data Triangulation

2.3.2.3.         Research Objective

Chapter 3.    Market Outlook

3.1.  Introduction

3.2.  Key Trends

3.2.1.Type Trends

3.2.2.Application Trends

3.2.3.End-User Trends

3.3.  Market Dynamics

3.3.1.Market Drivers

3.3.1.1.         Impact Analysis of Market Drivers

3.3.2.Market Restraints

3.3.2.1.         Impact Analysis of Market Restraints

3.3.3.Market Opportunities

3.3.3.1.         Impact Analysis of Market Opportunities

3.3.4.Market Challenges

3.3.4.1.         Impact Analysis of Market Challenges

3.4.  Porter’s Five Forces’ Analysis

3.4.1.Bargaining Power of Suppliers

3.4.2.Bargaining Power of Buyers

3.4.3.Threat of New Entrant

3.4.4.Threat of Substitutes

3.4.5.Competitive Rivalry

3.5.  Value Chain Analysis

3.6.  COVID-19 Impact Assessment in Nuclear Medicine Therapy Market

3.6.1.Impact Assessment on Global Nuclear Medicine Therapy Market

3.6.2.Market Trends and Opportunities in the Covid-19 Landscape

3.7.  Industry SWOT Analysis: Global Nuclear Medicine Therapy Market

3.8.  PESTLE Analysis: Global Nuclear Medicine Therapy Market

Chapter 4.    Competitive Landscape

4.1.  Global Nuclear Medicine Therapy Market Revenue and Share by Manufacturers (2023 and 2024)

4.2.  Global Nuclear Medicine Therapy Market Concentration Rate

4.2.1.Nuclear Medicine Therapy Market Share of Top 3 and Top 5 Manufacturers

4.3.    Competitive Environment, 2024

4.3.1.Player Competition Dashboard, 2024

4.3.2.Heat Map Analysis – Market Competition

4.3.3.Pyramid Analysis – Tier Wise Ranking

4.4.    Strategic Framework

4.4.1.Partnership/Collaborations/Agreement

4.4.2.Expansion

4.4.3.Mergers & Acquisitions

4.4.4.New Product Development

Chapter 5.    Global Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

5.1.  Global Nuclear Medicine Therapy Market Share, By Type, 2020 - 2032 (USD Million)

5.1.1.Radioisotope Therapy

5.1.1.1.         Overview

5.1.1.2.         Market Size and Projections, 2020 - 2032 (USD Million)

5.1.2.Peptide Receptor Radionuclide Therapy (PRRT)

5.1.2.1.         Overview

5.1.2.2.         Market Size and Projections, 2020 - 2032 (USD Million)

5.1.3.Radioimmunotherapy

5.1.3.1.         Overview

5.1.3.2.         Market Size and Projections, 2020 - 2032 (USD Million)

5.1.4.Brachytherapy

5.1.4.1.         Overview

5.1.4.2.         Market Size and Projections, 2020 - 2032 (USD Million)

5.2.  Market Attractiveness Analysis, by Type

Chapter 6.    Global Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

6.1.  Global Nuclear Medicine Therapy Market Share, By Application, 2020 - 2032 (USD Million)

6.1.1.Cancer Treatment

6.1.1.1.         Overview

6.1.1.2.         Market Size and Projections, 2020 - 2032 (USD Million)

6.1.2.Cardiovascular Disorders

6.1.2.1.         Overview

6.1.2.2.         Market Size and Projections, 2020 - 2032 (USD Million)

6.1.3.Neurological Disorders

6.1.3.1.         Overview

6.1.3.2.         Market Size and Projections, 2020 - 2032 (USD Million)

6.1.4.Thyroid Disorders

6.1.4.1.         Overview

6.1.4.2.         Market Size and Projections, 2020 - 2032 (USD Million)

6.2.  Market Attractiveness Analysis, by Application

Chapter 7.    Global Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

7.1.  Global Nuclear Medicine Therapy Market Share, By End-User, 2020 - 2032 (USD Million)

7.1.1.Hospitals

7.1.1.1.         Overview

7.1.1.2.         Market Size and Projections, 2020 - 2032 (USD Million)

7.1.2.Diagnostic Centers

7.1.2.1.         Overview

7.1.2.2.         Market Size and Projections, 2020 - 2032 (USD Million)

7.1.3.Research Laboratories

7.1.3.1.         Overview

7.1.3.2.         Market Size and Projections, 2020 - 2032 (USD Million)

7.2.  Market Attractiveness Analysis, by End-User

Chapter 8.    Global Nuclear Medicine Therapy Market Overview, By Geography, 2020 - 2032 (USD Million)

8.1.  Global Nuclear Medicine Therapy Market Share, By Geography, 2020 - 2032 (USD Million)

8.1.1.Market Size and Projections, by Countries, 2020 - 2032 (USD Million)

8.1.2.Market Share and CAGR Comparison, by Countries, 2023 and 2030 (%)

8.2.  Market Attractiveness Analysis, by Geography

Chapter 9.    North America Nuclear Medicine Therapy Market Overview, By Countries, 2020 - 2032 (USD Million)

9.1.    North America Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

9.1.1.     Market size and projections, 2020 - 2032 (USD Million)

9.1.2.     North America Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

9.1.3.     North America Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

9.1.4.     North America Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

9.2.    North America Nuclear Medicine Therapy Market Overview, By Countries, 2020 - 2032 (USD Million)

9.2.1.     U.S. Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

9.2.1.1.         U.S. Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

9.2.1.2.         U.S. Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

9.2.1.3.         U.S. Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

9.2.2.     Canada Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

9.2.2.1.         Canada Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

9.2.2.2.         Canada Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

9.2.2.3.         Canada Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

9.2.3.     Mexico Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

9.2.3.1.         Mexico Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

9.2.3.2.         Mexico Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

9.2.3.3.         Mexico Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

Chapter 10.  Europe Nuclear Medicine Therapy Market Overview, By Countries, 2020 - 2032 (USD Million)

10.1.Europe Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

10.1.1.   Market size and projections, 2020 - 2032 (USD Million)

10.1.2.   Europe Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

10.1.3.   Europe Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

10.1.4.   Europe Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

10.2.Europe Nuclear Medicine Therapy Market Overview, By Countries, 2020 - 2032 (USD Million)

10.2.1.   Germany Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

10.2.1.1.       Germany Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

10.2.1.2.       Germany Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

10.2.1.3.       Germany Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

10.2.2.   France Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

10.2.2.1.       France Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

10.2.2.2.       France Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

10.2.2.3.       France Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

10.2.3.   UK Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

10.2.3.1.       UK Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

10.2.3.2.       UK Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

10.2.3.3.       UK Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

10.2.4.   Italy Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

10.2.4.1.       Italy Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

10.2.4.2.       Italy Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

10.2.4.3.       Italy Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

10.2.5.   Russia Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

10.2.5.1.       Russia Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

10.2.5.2.       Russia Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

10.2.5.3.       Russia Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

10.2.6.   Rest of Europe Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

10.2.6.1.       Rest of Europe Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

10.2.6.2.       Rest of Europe Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

10.2.6.3.       Rest of Europe Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

Chapter 11.  Asia Pacific Nuclear Medicine Therapy Market Overview, By Countries, 2020 - 2032 (USD Million)

11.1.Asia Pacific Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

11.1.1.   Market size and projections, 2020 - 2032 (USD Million)

11.1.2.   Asia Pacific Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

11.1.3.   Asia Pacific Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

11.1.4.   Asia Pacific Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

11.2.Asia Pacific Nuclear Medicine Therapy Market Overview, By Countries, 2020 - 2032 (USD Million)

11.2.1.   India Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

11.2.1.1.       India Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

11.2.1.2.       India Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

11.2.1.3.       India Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

11.2.2.   China Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

11.2.2.1.       China Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

11.2.2.2.       China Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

11.2.2.3.       China Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

11.2.3.   Japan Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

11.2.3.1.       Japan Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

11.2.3.2.       Japan Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

11.2.3.3.       Japan Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

11.2.4.   South Korea Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

11.2.4.1.       South Korea Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

11.2.4.2.       South Korea Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

11.2.4.3.       South Korea Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

11.2.5.   Australia Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

11.2.5.1.       Australia Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

11.2.5.2.       Australia Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

11.2.5.3.       Australia Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

11.2.6.   Rest of Asia Pacific Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

11.2.6.1.       Rest of Asia Pacific Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

11.2.6.2.       Rest of Asia Pacific Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

11.2.6.3.       Rest of Asia Pacific Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

Chapter 12.  South America Nuclear Medicine Therapy Market Overview, By Countries, 2020 - 2032 (USD Million)

12.1.South America Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

12.1.1.   Market size and projections, 2020 - 2032 (USD Million)

12.1.2.   South America Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

12.1.3.   South America Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

12.1.4.   South America Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

12.2.South America Nuclear Medicine Therapy Market Overview, By Countries, 2020 - 2032 (USD Million)

12.2.1.   Brazil Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

12.2.1.1.       Brazil Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

12.2.1.2.       Brazil Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

12.2.1.3.       Brazil Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

12.2.2.   Argentina Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

12.2.2.1.       Argentina Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

12.2.2.2.       Argentina Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

12.2.2.3.       Argentina Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

12.2.3.   Rest of South America Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

12.2.3.1.       Rest of South America Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

12.2.3.2.       Rest of South America Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

12.2.3.3.       Rest of South America Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

Chapter 13.  Middle East & Africa Nuclear Medicine Therapy Market Overview, By Countries, 2020 - 2032 (USD Million)

13.1.Middle East & Africa Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

13.1.1.   Market size and projections, 2020 - 2032 (USD Million)

13.1.2.   Middle East & Africa Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

13.1.3.   Middle East & Africa Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

13.1.4.   Middle East & Africa Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

13.2.Middle East & Africa Nuclear Medicine Therapy Market Overview, By Countries, 2020 - 2032 (USD Million)

13.2.1.   GCC Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

13.2.1.1.       GCC Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

13.2.1.2.       GCC Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

13.2.1.3.       GCC Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

13.2.2.   South Africa Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

13.2.2.1.       South Africa Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

13.2.2.2.       South Africa Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

13.2.2.3.       South Africa Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

13.2.3.   Rest of Middle East & Africa Nuclear Medicine Therapy Market Overview, 2020 - 2032 (USD Million)

13.2.3.1.       Rest of Middle East & Africa Nuclear Medicine Therapy Market Overview, By Type, 2020 - 2032 (USD Million)

13.2.3.2.       Rest of Middle East & Africa Nuclear Medicine Therapy Market Overview, By Application, 2020 - 2032 (USD Million)

13.2.3.3.       Rest of Middle East & Africa Nuclear Medicine Therapy Market Overview, By End-User, 2020 - 2032 (USD Million)

Chapter 14.  Key Vendor Analysis

14.1.General Electric Company*

14.1.1.       Business Overview

14.1.2.       Product Benchmarking

14.1.3.       Financial Data

14.1.4.       SWOT Analysis

14.1.5.       Strategic Overview

14.1.6.       Key Developments

*Similar sub-pointers will be included for rest of the companies listed below

14.2.Siemens Healthineers

14.3.Bayer AG

14.4.Thermo Fisher Scientific

14.5.Bracco Imaging S.p.A

14.6.Lantheus Medical Imaging, Inc.

14.7.Mallinckrodt Pharmaceuticals

14.8.Cardinal Health, Inc.

14.9.GE Healthcare

14.10.           Advanced Accelerator Applications

Chapter 15.  Key Conclusions & Analyst Recommendations

Disclaimer